aTYR PHARMA INC
ATYR- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001339970
近 90 天,aTYR PHARMA INC 沒有內部人公開市場買賣的申報;2026 年第 2 季末有 89 家機構在 13F 申報持有,市值合計 $2,318 萬;沒有大師持有。
SEC 申報
aTYR PHARMA INC 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F,最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀;8-K 的新聞稿等附件(例如 Item 2.02 的 EX-99.1)在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/13 | 8-K | 8.01 | 2026/11/13 | SEC | 目錄 |
| 2026/11/6 | 8-K | 8.019.01 | 2026/11/6 | SEC | 目錄 |
| 2026/11/6 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/5 | 8-K | 2.029.01 | 2026/11/5 | SEC | 目錄 |
| 2026/10/27 | 8-K | 5.039.01 | 2026/10/27 | SEC | 目錄 |
| 2026/10/16 | 8-K | 5.07 | 2026/10/16 | SEC | 目錄 |
| 2026/9/24 | 8-K | 8.01 | 2026/9/24 | SEC | 目錄 |
| 2026/8/7 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/7 | 8-K | 2.029.01 | 2026/8/7 | SEC | 目錄 |
| 2026/7/31 | 8-K | 1.029.01 | 2026/7/30 | SEC | 目錄 |
| 2026/6/8 | 8-K | 3.01 | 2026/6/3 | SEC | 目錄 |
| 2026/6/1 | 8-K | 7.019.01 | 2026/6/1 | SEC | 目錄 |
| 2026/5/15 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/15 | 8-K | 2.029.01 | 2026/5/15 | SEC | 目錄 |
| 2026/5/11 | 8-K | 2.027.018.019.01 | 2026/5/11 | SEC | 目錄 |
| 2026/3/5 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/3/5 | 8-K | 2.029.01 | 2026/3/5 | SEC | 目錄 |
| 2025/12/5 | 8-K | 3.01 | 2025/12/4 | SEC | 目錄 |
| 2025/11/6 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/6 | 8-K | 2.029.01 | 2025/11/6 | SEC | 目錄 |
| 2025/9/15 | 8-K | 8.019.01 | 2025/9/15 | SEC | 目錄 |
| 2025/8/8 | 8-K/A | 2.029.01 | 2025/8/7 | SEC | 目錄 |
| 2025/8/7 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/7 | 8-K | 2.069.01 | 2025/8/7 | SEC | 目錄 |
| 2025/5/7 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/7 | 8-K | 2.029.01 | 2025/5/7 | SEC | 目錄 |
| 2025/5/6 | 8-K | 5.025.079.01 | 2025/5/1 | SEC | 目錄 |
| 2025/3/13 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/3/13 | 8-K | 2.029.01 | 2025/3/13 | SEC | 目錄 |
| 2024/12/23 | 8-K | 1.019.01 | 2024/12/23 | SEC | 目錄 |
| 2024/12/12 | 8-K | 5.029.01 | 2024/12/10 | SEC | 目錄 |
| 2024/11/7 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/7 | 8-K | 2.029.01 | 2024/11/7 | SEC | 目錄 |
| 2024/8/13 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/13 | 8-K | 2.029.01 | 2024/8/13 | SEC | 目錄 |
| 2024/7/22 | 8-K | 8.01 | 2024/7/22 | SEC | 目錄 |
| 2024/5/29 | 8-K | 5.025.055.078.019.01 | 2024/5/22 | SEC | 目錄 |
| 2024/5/2 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/2 | 8-K | 2.029.01 | 2024/5/2 | SEC | 目錄 |
| 2024/3/14 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/3/14 | 8-K | 2.029.01 | 2024/3/14 | SEC | 目錄 |
| 2023/11/9 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/11/9 | 8-K | 2.029.01 | 2023/11/9 | SEC | 目錄 |
| 2023/9/26 | 8-K | 7.018.019.01 | 2023/9/26 | SEC | 目錄 |
| 2023/9/11 | 8-K | 8.01 | 2023/9/10 | SEC | 目錄 |
| 2023/8/9 | 10-Q | – | 2023/6/30 | SEC | 目錄 |
| 2023/8/9 | 8-K | 2.029.01 | 2023/8/9 | SEC | 目錄 |
| 2023/5/19 | 8-K | 5.025.035.055.079.01 | 2023/5/17 | SEC | 目錄 |
| 2023/5/9 | 10-Q | – | 2023/3/31 | SEC | 目錄 |
| 2023/5/9 | 8-K | 2.029.01 | 2023/5/9 | SEC | 目錄 |